Investigating the glymphatic system's role in migraine
Official title: Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine Attack
Run by IRCCS San Raffaele · NCT05907655 · Data updated 2026-11-12
This study is trying to see how the brain's cleaning system might affect migraine attacks by looking at brain scans and sleep patterns in people with migraines and healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, Milan) |
| Status | Recruiting |
| Started | April 30, 2023 |
| Main results expected | March 30, 2027 |
| Study ends | April 4, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT05907655 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 60 with a diagnosis of migraine according to ICHD-3 criteria.
✕Probably not a fit
Patients with overuse of acute headache medications or other primary headache disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores how the glymphatic system may contribute to migraine attacks by utilizing non-invasive MRI techniques and a model that induces migraines through nitroglycerin administration. It aims to assess the relationship between glymphatic function during migraine episodes, sleep patterns, and levels of neuropeptides associated with migraines. Participants will include individuals diagnosed with migraines and healthy controls, all aged between 18 and 60 years.
Why it matters
Potential benefit: If successful, this study could enhance understanding of migraine mechanisms and lead to improved treatment strategies.
How similar studies have gone: While the glymphatic system's role in migraines is a relatively novel area of investigation, similar studies have shown promising results in understanding other neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For patients: • Diagnosis of migraine, by the ICHD-3 criteria; For both patients and healthy controls: * Age between 18 and 60 years; * Willing and able to comply with scheduled visits. Exclusion criteria For patients: * Overuse of acute medications for headache; * Continuous or daily headache; * Other primary headache disorders, with the exception of infrequent tension-type headache. For healthy controls: • Any subject with frequent tension type headache, migraine, cluster headache, other pain syndromes or neurological conditions. For both patients and healthy controls: * Allergy to nitroglycerin; * Major psychiatric disorders such as bipolar affective disorder and schizophrenia; * Cardiovascular diseases that contraindicated the use of nitroglycerin; * Intracranial hypertension; * Cerebral haemorrhage; * Cerebral trauma; * Pulmonary toxic oedema; * Closed angle glaucoma; * Anaemia; * Pregnancy and breastfeeding; * Aortic stenosis or significant hypotension (SBP\<90mmHg or \<100mmHg and symptomatic) precluding nitroglycerin administration; * Use of sildenafil; * Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study; * Any person where MRI scanning is contraindicated (metal implants, pacemaker, claustrophobia, etc.); * Use of illicit drugs; * MRI head showing any brain pathology, such as space-occupying lesions; * Any person unable to understand and follow the instructions of the investigators.
Where it's running
-
IRCCS San Raffaele Hospital
Milan, Milan, Italy Recruiting
Study contacts
- Principal investigator: Roberta Messina, MD, PhD — IRCCS San Raffaele Hospital
- Study coordinator: Roberta Messina, MD, PhD
- Email: messina.roberta@hsr.it
- Phone: 00390226433944
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Elismetrep (K-304) for acute treatment of migraine
This study tests whether a single dose of elismetrep can quickly lessen the pain of a migraine compared with placebo in adults 18 to 75.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Online Hatha Yoga Add-On for High-Frequency Episodic Migraine
This trial tests whether a 12-week online Hatha yoga program added to usual migraine treatment can help adults with high-frequency episodic migraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.